From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Aon plc $AON director Lester B. Knight.

Knight reported a purchase of 50,000 AON shares, equivalent to $15 million.

This is the video recording of the February 9, 2024, Hot Corner Insider Weekly Strategy Session.

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Venrock Healthcare Capital Partners.

The firm reported a purchase of roughly $1.2 million in KalVista Pharmaceuticals Inc $KALV.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Magnolia Capital Fund.

The investment firm revealed a purchase of $2.5 million in America’s Car-Mart Inc $CRMT.

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Farhad Nanji, director at RXO Inc $RXO.

Nanji revealed a purchase of 747,424 RXO shares, equivalent to $15 million.

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Warren Buffett and Berkshire Hathaway.

Buffett and Berkshire reported another substantial purchase in Occidental Petroleum Corp $OXY, this time with a total value of $245  million.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes via Form 4 filings by Warren Buffett and Berkshire Hathaway.

Buffett and Berkshire reported additional purchases in The Liberty SiriusXM Group  for a total amount of $55,438,736.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Maha Katabi, director of Vera Therapeutics $VERA.

Katabi reported a purchase of 161,290 VERA shares, equivalent to $5 million.

This is the video recording of the January 31, 2024, Hot Corner Insider Weekly Strategy Session.

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Gilead Sciences.

The American biopharmaceutical company revealed a purchase of roughly $320 million in Arcus Biosciences Inc $RCUS, increasing its ownership stake to 40%.